Protocol No.: R3918-AMD-2326-SIENNA

A MULTICENTER, RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY, SAFETY, AND TOLERABILITY OF SUBCUTANEOUSLY ADMINISTERED POZELIMAB IN COMBINATION WITH CEMDISIRAN OR CEMDISIRAN ALONE IN PARTICIPANTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Principal Investigator
Ghorayeb, Ghassan
Phase
III
Age Group
Adult
Applicable Disease Site
Other
Participating Institutions
Eye Institute
West Virginia University
Contacts
Athena Echols
Clinical Trials Coordinator
Phone: +1 304-598-6977
Mariah Allen
Certified Ophthalmic Assistant
Phone: +1 304-974-4101

View on ClinicalTrials.gov